0001485003-16-000120.txt : 20160629 0001485003-16-000120.hdr.sgml : 20160629 20160629161421 ACCESSION NUMBER: 0001485003-16-000120 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160627 FILED AS OF DATE: 20160629 DATE AS OF CHANGE: 20160629 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 252025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-871-9911 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Celniker Abbie CENTRAL INDEX KEY: 0001590250 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 161738969 MAIL ADDRESS: STREET 1: C/O ELEVEN BIOTHERAPEUTICS, INC. STREET 2: 215 FIRST STREET, SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 wf-form4_146723124831863.xml FORM 4 X0306 4 2016-06-27 0 0001485003 Eleven Biotherapeutics, Inc. EBIO 0001590250 Celniker Abbie C/O ELEVEN BIOTHERAPEUTICS, INC., 215 FIRST STREET, SUITE 400 CAMBRIDGE MA 02142 1 1 0 0 President and CEO Common Stock 2016-06-27 4 S 0 10029 2.08 D 419946 D The shares of common stock underlying the restricted stock units reported as disposed herein were sold by the issuer in satisfaction of tax withholding obligations associated with the vesting of such units. /s/ John J. McCabe as attorney-in-fact 2016-06-29